Chongqing Zhifei Stock Hits Day Low Amid Price Pressure, Closing at CNY 15.97

Chongqing Zhifei Biological Products Co., Ltd. has experienced a notable decline today, with the stock dropping by 3.91% as it reached an intraday low of CNY 15.97. This performance marks a stark contrast to the China Shanghai Composite, which fell by only 1.26% on the same day. Over the past week, Chongqing Zhifei has seen a decrease of 6.6%, and its performance over the last month shows a decline of 7.2%. The company's year-to-date performance stands at a loss of 15.32%, while its one-year performance reflects a significant drop of 36.28%. The long-term outlook is concerning, with a staggering 81.98% decline over the past three years and a 91.53% drop over the last five years. Financial metrics indicate a challenging environment for the company, with net sales for the latest quarter falling by 63.57% to CNY 2,362.25 million and a net profit of CNY -303.21 million, representing a 160.09% decline. The operating cash flow has also reached a low of CNY 163.84 million. These figures highlight the ongoing difficulties faced by Chongqing Zhifei in the competitive pharmaceuticals and biotechnology sector.